About the Authors
- Paulo A. Garcia
-
* E-mail: pgarcia@vt.edu (PAG); tlellis@wakehealth.edu (TLE)
Affiliation Bioelectromechanical Systems Lab, School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, Virginia, United States of America
- John H. Rossmeisl Jr
-
Affiliation Neurology and Neurosurgery, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, Virginia, United States of America
- John L. Robertson
-
Affiliation Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Blacksburg, Virginia, United States of America
- John D. Olson
-
Affiliation Center for Biomolecular Imaging, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
- Annette J. Johnson
-
Affiliation Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
- Thomas L. Ellis
-
* E-mail: pgarcia@vt.edu (PAG); tlellis@wakehealth.edu (TLE)
Affiliation Department of Neurosurgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America
- Rafael V. Davalos
-
Affiliation Bioelectromechanical Systems Lab, School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, Virginia, United States of America
Competing Interests
The authors have read the journal's policy and have the following conflicts. PAG, JHR, JLR, and RVD have patents pending on the irreversible electroporation technology. Specifically, the submitted patent applications are described: 1. MB Sano, RV Davalos, JL Robertson. Irreversible Electroporation using Tissue Vasculature to Treat Aberrant Cell Masses or Create Tissue Scaffolds. PCT/US Application 11/62067. Filing Date 11/23/11 Pending. 2. RE Neal II, PA Garcia, RV Davalos, JH Rossmeisl, Jr., JL Robertson. Treatment Planning for Electroporation-Based Therapies. US Application 12/906,923. Filing Date: 10/18/10 Pending. 3. RV Davalos, PA Garcia, JL Robertson, JH Rossmeisl, Jr., RE Neal II. Irreversible Electroporation to Treat Aberrant Cell Masses. US Application 12/491,151. Filing Date: 6/24/09 Pending. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: PAG JHR JLR JDO AJJ TLE RVD. Performed the experiments: PAG JHR JLR JDO AJJ TLE RVD. Analyzed the data: PAG JHR. Contributed reagents/materials/analysis tools: PAG JHR JLR JDO AJJ TLE RVD. Wrote the paper: PAG JHR JLR JDO AJJ TLE RVD.